INSR: Insulin receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor tyrosine kinase which mediates the pleiotropic actions of insulin.
- Drugs that act on it: 30
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Insulin degludec | Approved | Insulin receptor agonist | Agonist | — |
| Insulin detemir | Approved | Insulin receptor agonist | Agonist | — |
| Insulin human | Approved | Insulin receptor agonist | Agonist | Boxed warning |
| Insulin icodec | Approved | Insulin receptor agonist | Agonist | — |
| Insulin susp isophane recombinant human | Approved | Insulin receptor agonist | Agonist | — |
| BMS-754807 | — | Insulin receptor inhibitor | Inhibitor | — |
| Insulin [injection], biphasic | — | Insulin receptor agonist | Agonist | — |
| Insulin aspart | — | Insulin receptor agonist | Agonist | — |
| Insulin aspart protamine recombinant | — | Insulin receptor agonist | Agonist | — |
| Insulin glargine | — | Insulin receptor agonist | Agonist | — |
| Insulin glulisine | — | Insulin receptor agonist | Agonist | — |
| Insulin human zinc | — | Insulin receptor agonist | Agonist | — |
| Insulin human, isophane | — | Insulin receptor agonist | Agonist | — |
| Insulin lispro | — | Insulin receptor agonist | Agonist | — |
| Insulin lispro protamine recombinant | — | Insulin receptor agonist | Agonist | — |
| Insulin peglispro | — | Insulin receptor agonist | Agonist | — |
| Insulin pork | — | Insulin receptor agonist | Agonist | — |
| Insulin purified beef | — | Insulin receptor agonist | Agonist | — |
| Insulin purified pork | — | Insulin receptor agonist | Agonist | — |
| Insulin susp isophane beef | — | Insulin receptor agonist | Agonist | — |
| Insulin susp isophane semisynthetic purified human | — | Insulin receptor agonist | Agonist | — |
| Insulin tregopil | — | Insulin receptor agonist | Agonist | — |
| Insulin zinc susp recombinant human | — | Insulin receptor agonist | Agonist | — |
| Insulin zinc, extended | — | Insulin receptor agonist | Agonist | — |
| Insulin zinc, prompt | — | Insulin receptor agonist | Agonist | — |
| Insulin, isophane | — | Insulin receptor agonist | Agonist | — |
| Insulin, neutral | — | Insulin receptor agonist | Agonist | — |
| Insulin, protamine zinc | — | Insulin receptor agonist | Agonist | — |
| KW-2450 free base | — | Insulin receptor inhibitor | Inhibitor | — |
| Linsitinib | — | Insulin receptor inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Donohue syndrome
- 0.85
- Insulin-resistance syndrome type A
- 0.85
- Rabson-Mendenhall syndrome
- 0.81
- Hyperinsulinism due to INSR deficiency
- 0.73
- Neurodegenerative disease
- 0.53
- Hypertensive disorder
- 0.51
- Hypothyroidism
- 0.44
Drugs and mechanisms are from ChEMBL CHEMBL1981 (CC BY-SA 3.0). Gene name, function (UniProt P06213, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets